Ocular involvement in children with beta-thalassemia major

Authors

  • B. Lubis Division of Pediatric Hematology and Oncology, Department of Pediatrics, Faculty of Medicine, Universitas Sumatera Utara – Medan, Indonesia Author
  • S. M. Lubis Division of Pediatric Endocrinology, Department of Pediatrics, Faculty of Medicine, Universitas Sumatera Utara – Medan, Indonesia Author
  • B. D. Sulistyowati Pediatric Ophthalmology Department, SMEC Eye Hospital – Medan, Indonesia Author

DOI:

https://doi.org/10.2478/AMB-2024-0048

Keywords:

beta-thalassemia, children, ocular abnormalities, ferritin

Abstract

Aim: Thalassemia is a severe genetic blood disorder, and several organs, including eyes, can be affected. The mechanism of ocular abnormalities in thalassemia is multifactorial; one of them is regular blood transfusion, which can cause iron overload. Ocular abnormalities can also occur because of the side effects of iron chelators. This study evaluated ocular involvement in children with Beta-thalassemia major and its association with serum ferritin levels. Methods: A cross-sectional study was undertaken at the Thalassemia daycare center in a tertiary referral hospital in Medan. All patients’ hemoglobin was measured before transfusion, and serum ferritin levels were measured at six-month intervals. A Pediatric Ophthalmologist carried out the ophthalmological assessment, which included a detailed history of visual problems and visual acuity testing. Fisher’s Exact test and Spearman test were used for 
statistical calculation. Results: Thirty-seven beta-thalassemia major children ranging from three to 18 years old. Visual acuity, anterior segment, fundus, and retina were evaluated. Ophthalmologic examinations showed that ocular involvement increased with age. Visual acuity was reduced in 16.2% of the subjects. Papilledema was the most common ocular finding among the subjects (13.5%), followed by cataracts (8.1%) and optic atrophy (8.1%). A significant correlation between blood transfusion volume and serum ferritin levels was found. Conclusion: Ocular involvement was found in more than half of the subjects in this study. However, regular ophthalmologic 
evaluations by serum ferritin examination were required to detect early alterations in their visual system for a better quality of life.

References

Vichinsky EP. Changing patterns of thalassemia worldwide. In: Ann N Y Acad Sci. 1054.; 2005:18-24.

Taher AT, Saliba AN. Iron overload in thalassemia: Different organs at different rates. Hematology. 2017; 2017(1):265-271.

Taher A, Bashshur Z, Shamseddeen WA, et al. Ocular findings among thalassemia patients. Am J Ophthalmol. 2006;142(4):704-705.

Thalassaemia International Federation. Guidelines for the Management of Transfusion Dependent Thalassemia (TDT); 2014.

Thuangtong A, Wiriyaudomchart S, Rungsiri K. Incidence of ocular toxicity from iron chelating agents at Siriraj Hospital. Siriraj Med J. 2020; 72(3):209-213.

Gartaganis S, Ismiridis K, Papageorgiou O, et al. Ocular abnormalities in patients with β thalassemia. Am J Ophthalmol. 1989; 108(6):699-703.

Wong RW, Richa DC, Hahn P, et al. Iron toxicity as a potential factor in AMD. Retina. 2007; 27(8):997-1003.

Merchant RH, Punde H, Thacker N, et al. Ophthalmic Evaluation in Beta-Thalassemia. Indian J Pediatr. 2017;84(7):509-514.

Jafari R, Heydarian S, Karami H, et al. Ocular abnormalities in multi-transfused beta-thalassemia patients. Indian J Ophthalmol. 2015;63(9):710-715.

Taneja R, Malik P, Sharma M, et al. Multiple transfused thalassemia major: Ocular manifestations in a hospital-based population. Indian J Ophthalmol. 2010; 58(2):125-130.

Gosai D, Mehariya K, Gosai J. Study of ocular manifestations in children of thalassemia. Int J Res Med Sci. 2014; 2(2):695-698.

Haghpanah S, Zekavat OR, Bordbar M, et al. Ocular findings in patients with transfusion-dependent β-thalassemia in southern Iran. BMC Ophthalmol. 2020; 20(1):376.

Loh A, Hadziahmetovic M, Dunaief JL. Iron homeostasis and eye disease. Biochim Biophys Acta - Gen Subj. 2009; 1790(7):637-649.

Wood JC. Diagnosis and management of transfusion iron overload: The role of imaging. Am J Hematol. 82.; 2007:1132-1135.

Susanah S, Idjradinata PS, Sari NM, et al. Time to Start Delivering Iron Chelation Therapy in Newly Diagnosed Severe β-Thalassemia. Sadikot R, ed. Biomed Res Int. 2020; 2020:8185016.

Downloads

Published

04.10.2024

How to Cite

Lubis, B., Lubis, S. M., & Sulistyowati, B. D. (2024). Ocular involvement in children with beta-thalassemia major. Acta Medica Bulgarica, 51(Suppl 2), 19-23. https://doi.org/10.2478/AMB-2024-0048